ENDOTHELIAL CELL DYSFUNCTION & APOPOTOSIS IN ACCELERATED GRAFT ARTERIOSCLEROSIS
ENDOTHELIAL CELL DYSFUNCTION & APOPOTOSIS IN ACCELERATED GRAFT ARTERIOSCLEROSIS
批准号:
6642364
负责人:
NICHOLAS A FLAVAHAN
金额:
$49.81万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2001
资助国家:
美国
项目状态:
已结题
起止时间:
2001-05-01 至 2003-04-30
关键词:
CD antigens apoptosis arteriosclerosis cell transplantation cellular pathology complement pathway coronary artery cytomegalovirus cytotoxic T lymphocyte electromyography free radicals guanine nucleotide binding protein heart transplantation immunocytochemistry laboratory mouse laboratory rat nuclear factor kappa beta oxidative stress phosphatidylserines receptor coupling transfection vascular endothelium
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Accelerated graft arteriosclerOsis (AGA) represents a major obstacle to
long term survival of heart transplant recipients. While it has become
clear that AGA is a multifactorial problem, the specific mechanisms
leading to AGA remain unknown. Because of their pivotal role in the
maintenance of vessel homeostasis, endothelial cells (EcS) are likely to
represent prime targets in the pathogenesis of AGA. Project 1 is designed
to provide in-depth characterization of the process that affects ECs in
AGA, from extracellular factors to intracellular molecular pathways that
transduce messages to the genome of ECs. By integrating our studies on ECs
with other projects of this program, we intend to provide information that
will be key to the development of specific strategies to suppress AGA. In
AGA, the functional damage to the endothelium is diffuse.
Morphologically, areas of endothelial erosion can be found dispersed along
the coronary vessels. Several mechanisms of BC ii-jury have been
implicated in AGA: (i) oxidative injury resulting from
ischemia/reperfusion at the time of surgery; (ii) immunological injuries
involving complement activation, processing and presentation of antigens,
activation and adhesion of T.lymphocytes, in particular cytolytic T-
lymphocytes (CTL), sequestration of monocytes, production of antibodies
against allo- or iso-antigens, and dysregulation of the immune system with
Cyclosporine A; (iii) injury with CMV-infection/reactivation; and (iv)
direct Cyclosporine A toxicity. These various mechanisms could contribute
either independently or in concert, to the diffuse abnormalities of ECs in
AGA. Particular emphasis will be placed on the following pathway, which
will provide the basis for the specific aims of this project: (i) the
initial injury results in uncoupling of Gi-2 from its membrane receptors;
(ii) the uncoupling of Gi-2 then results in BC dysfunction and
overexpression of Fas on the surface of ECs, through a pathway that
requires NF-kappaB activation; (iii) overexpression of Fas, in turn,
results in the "kiss of death" as CTL bind to the ECs through the
interaction of Fas and Fas-ligand present on the CTL surface; (iv)
increased BC apoptosis will further aggravate the dysfunctional aspect of
the endothelium and promote fibrin production and deposition due to the
abnormal presence of phosphatidylserine on the surface of ECs. As a
result, the endothelium in these patients is not capable of carrying out
its usual functions namely, vasodilation, anti-thrombotic effect, anti-
proliferative effect for the cells of the vessel wall, control of the
attachment of inflammatory cells, and homeostasis of extracellular protein
production, leading to the development of AGA.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Impaired Endothelial Maturation and the Developmental Origin of Vascular Disease
-
批准号:9279232
-
项目类别:
-
资助金额:$33.62万
-
财政年份:2014
-
负责人:NICHOLAS A FLAVAHAN
-
依托单位:
Impaired Endothelial Maturation and the Developmental Origin of Vascular Disease
-
批准号:8759467
-
项目类别:
-
资助金额:$33.62万
-
财政年份:2014
-
负责人:NICHOLAS A FLAVAHAN
-
依托单位:
Impaired Endothelial Maturation and the Developmental Origin of Vascular Disease
-
批准号:9085330
-
项目类别:
-
资助金额:$33.28万
-
财政年份:2014
-
负责人:NICHOLAS A FLAVAHAN
-
依托单位:
Endothelial exocytosis and the vascular dysfunction of aging
-
批准号:8059698
-
项目类别:
-
资助金额:$24.6万
-
财政年份:2010
-
负责人:NICHOLAS A FLAVAHAN
-
依托单位:
Endothelial exocytosis and the vascular dysfunction of aging
-
批准号:7878227
-
项目类别:
-
资助金额:$20.5万
-
财政年份:2010
-
负责人:NICHOLAS A FLAVAHAN
-
依托单位:
Mechanisms of Vascular Dysfunction in Vibration Injury
-
批准号:7390919
-
项目类别:
-
资助金额:$25.38万
-
财政年份:2006
-
负责人:NICHOLAS A FLAVAHAN
-
依托单位:
Mechanisms of Vascular Dysfunction in Vibration Injury
-
批准号:7422526
-
项目类别:
-
资助金额:$3.22万
-
财政年份:2006
-
负责人:NICHOLAS A FLAVAHAN
-
依托单位:
Mechanisms of Vascular Dysfunction in Vibration Injury
-
批准号:7491610
-
项目类别:
-
资助金额:$25.9万
-
财政年份:2005
-
负责人:NICHOLAS A FLAVAHAN
-
依托单位:
Mechanisms of Vascular Dysfunction in Vibration Injury
-
批准号:7255586
-
项目类别:
-
资助金额:$25.9万
-
财政年份:2005
-
负责人:NICHOLAS A FLAVAHAN
-
依托单位:
alpha2C Adrenergic Receptors & Cutaneous Circulation
-
批准号:6903241
-
项目类别:
-
资助金额:$33.64万
-
财政年份:2005
-
负责人:NICHOLAS A FLAVAHAN
-
依托单位:
alpha2C Adrenergic Receptors & Cutaneous Circulation
-
批准号:7013153
-
项目类别:
-
资助金额:$32.85万
-
财政年份:2005
-
负责人:NICHOLAS A FLAVAHAN
-
依托单位:
alpha2C Adrenergic Receptors & Cutaneous Circulation
-
批准号:7171870
-
项目类别:
-
资助金额:$34.95万
-
财政年份:2005
-
负责人:NICHOLAS A FLAVAHAN
-
依托单位:
alpha2C Adrenergic Receptors & Cutaneous Circulation
-
批准号:7383892
-
项目类别:
-
资助金额:$34.99万
-
财政年份:2005
-
负责人:NICHOLAS A FLAVAHAN
-
依托单位:
alpha2C Adrenergic Receptors & Cutaneous Circulation
-
批准号:7568200
-
项目类别:
-
资助金额:$34.99万
-
财政年份:2005
-
负责人:NICHOLAS A FLAVAHAN
-
依托单位:
Mechanisms of Vascular Dysfunction in Vibration Injury
-
批准号:7635844
-
项目类别:
-
资助金额:$25.9万
-
财政年份:2005
-
负责人:NICHOLAS A FLAVAHAN
-
依托单位:
Mechanisms of Vascular Dysfunction in Vibration Injury
-
批准号:6959114
-
项目类别:
-
资助金额:$22.94万
-
财政年份:2005
-
负责人:NICHOLAS A FLAVAHAN
-
依托单位:
Redox Regulation of Arteriole Function
-
批准号:6499178
-
项目类别:
-
资助金额:$33.08万
-
财政年份:2001
-
负责人:NICHOLAS A FLAVAHAN
-
依托单位:
Redox Regulation of Arteriole Function
-
批准号:6852692
-
项目类别:
-
资助金额:$33.19万
-
财政年份:2001
-
负责人:NICHOLAS A FLAVAHAN
-
依托单位:
Redox Regulation of Arteriole Function
-
批准号:6697310
-
项目类别:
-
资助金额:$33.19万
-
财政年份:2001
-
负责人:NICHOLAS A FLAVAHAN
-
依托单位:
Redox Regulation of Arteriole Function
-
批准号:6323901
-
项目类别:
-
资助金额:$35.58万
-
财政年份:2001
-
负责人:NICHOLAS A FLAVAHAN
-
依托单位:
国内基金
海外基金
登录
查看更多内容
Epac1/2通过蛋白酶体调控中性粒细胞NETosis和Apoptosis在急性肺损伤中的作用研究
-
批准号:LBY21H010001
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2020
-
负责人:郑绪阳
-
依托单位:
基于Apoptosis/Ferroptosis双重激活效应的天然产物AlbiziabiosideA的抗肿瘤作用机制研究及其结构改造
-
批准号:81703335
-
项目类别:青年科学基金项目
-
资助金额:20.0万元
-
批准年份:2017
-
负责人:卫高菲
-
依托单位:
双肝移植后Apoptosis和pyroptosis在移植物萎缩差异中的作用和供受者免疫微环境变化研究
-
批准号:81670594
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2016
-
负责人:陈昊
-
依托单位:
Serp-2 调控apoptosis和pyroptosis 对肝脏缺血再灌注损伤的保护作用研究
-
批准号:81470791
-
项目类别:面上项目
-
资助金额:73.0万元
-
批准年份:2014
-
负责人:董家鸿
-
依托单位:
Apoptosis signal-regulating kinase 1是七氟烷抑制小胶质细胞活化的关键分子靶点?
-
批准号:81301123
-
项目类别:青年科学基金项目
-
资助金额:23.0万元
-
批准年份:2013
-
负责人:王海莲
-
依托单位:
APO-miR(multi-targeting apoptosis-regulatory miRNA)在前列腺癌中的表达和作用
-
批准号:81101529
-
项目类别:青年科学基金项目
-
资助金额:22.0万元
-
批准年份:2011
-
负责人:陈雪芹
-
依托单位:
放疗与细胞程序性死亡(APOPTOSIS)相关性及其应用研究
-
批准号:39500043
-
项目类别:青年科学基金项目
-
资助金额:9.0万元
-
批准年份:1995
-
负责人:梁克
-
依托单位: